Home LiteratureArticle Details
PMID: 103841 Published · ppublish English Journal Article

Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa.

Infection and immunity ·Vol. 22 ·No. 3 ·1978-12-00 ·Pages 919-25

Pier GB, Sidberry HF, Sadoff JC

Abstract

A high-molecular-weight alkali-labile polysaccharide (PS) isolated from the slime of immunotype 1 Pseudomonas aeruginosa was tested for its ability to protect mice from lethal challenge with the live, homologous organism. Intraperitoneal (i.p.) injection of 10 to 25 microgram of the PS protected 60 to 70% of the mice against challenge with up to 50 50% lethal dose units. Although single immunization of mice with up to 250 microgram of PS effected protective levels of only 70%, two successive immunizations provided 100% protection. Subcutaneous and intravenous immunization with PS also provided protection to i.p. challenges with immunotype 1 P. aeruginosa, but not to i.p. challenge with immunotype 4 P. aeruginosa. Although lipopolysaccharide (LPS) was found to be more immunogenic than PS in out studies, contamination of the alkali-labile PS with LPS did not account for the protection seen. Alkali treatment (0.1 N NaOH, 37 degrees C, 2 h) of the PS destroyed its protective effectiveness, while similarly treated LPS retained its capacity for inducing immunity in mice. Adsorption and passive protection studies with sera raised to either PS or a mixture of PS and LPS indicated that antibody directed to the alkali-labile PS antigen was capable of contributing to the protection of mice against challenge with P. aeruginosa.

MeSH Terms
Animals Antibodies, Bacterial/biosynthesis,immunology Antigens, Bacterial Immunity, Active Immunization, Passive Mice Mice, Inbred ICR Polysaccharides, Bacterial/immunology Pseudomonas Infections/immunology Pseudomonas aeruginosa/immunology
Chemicals
Antibodies, Bacterial Antigens, Bacterial Polysaccharides, Bacterial
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Pier G B
Sidberry H F
Sadoff J C
References (22)
22 references, click to expand
  1. Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae: current status of polyvalent vaccines.
    J Infect Dis. 1977 Aug;136 Suppl:S38-42 PMID: 19543
  2. A Clinical Lecture ON A CASE OF BACILLUS PYOCYANEUS PYAEMIA SUCCESSFULLY TREATED BY VACCINE: Delivered at the Bristol General Hospital.
    Br Med J. 1909 May 15;1(2524):1169-70 PMID: 20764470
  3. Isolation and characterization of a high-molecular-weight polysaccharide from the slime of Pseudomonas aeruginosa.
    Infect Immun. 1978 Dec;22(3):908-18 PMID: 103840
  4. A new polyvalent Pseudomonas vaccine.
    J Med Microbiol. 1977 Feb;10(1):19-27 PMID: 402473
  5. Direct evidence for the presence of lipopolysaccharide components in Pseudomonas ribosomal vaccine.
    Infect Immun. 1977 Aug;17(2):471-3 PMID: 408275
  6. Analysis of parameters affecting the solid phase radioimmunoassay quantitation of antibody to meningococcal antigens.
    J Immunol. 1976 Nov;117(5 Pt.2):1788-98 PMID: 825573
  7. Infections caused by Pseudomonas species in patients with burns and in other surgical patients.
    J Infect Dis. 1974 Nov;130 Suppl(0):S8-13 PMID: 4138183
  8. Pseudomonas aeruginosa vaccine in cancer patients.
    Ann Intern Med. 1973 Oct;79(4):518-27 PMID: 4201225
  9. Nosocomial infections due to Pseudomonas.
    J Infect Dis. 1974 Nov;130 Suppl(0):S4-7 PMID: 4213715
  10. Bacteremia due to Pseudomonas aeruginosa complicating neoplastic disease: a progress report.
    J Infect Dis. 1974 Nov;130 Suppl(0):S14-23 PMID: 4213872
  11. Significance of Pseudomonas aeruginosa in the patient with leukemia or lymphoma.
    J Infect Dis. 1974 Nov;130 Suppl(0):S24-31 PMID: 4213977
  12. Specificity of the protective response induced by the slime layer of Pseudomonas aeruginosa.
    J Hyg (Lond). 1974 Aug;73(1):75-84 PMID: 4213979
  13. Preliminary investigations of Pseudomonas aeruginosa vaccine in patients with leukemia and cystic fibrosis.
    J Infect Dis. 1974 Nov;130 Suppl(0):S159-62 PMID: 4213986
  14. Pseudomonas aeruginosa infections.
    CRC Crit Rev Clin Lab Sci. 1972 Sep;3(3):291-347 PMID: 4376736
  15. Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b.
    Pediatrics. 1973 Nov;52(5):637-44 PMID: 4542777
  16. The effect of ethylenediaminetetra-acetic acid on the cell walls of some gram-negative bacteria.
    J Gen Microbiol. 1965 Jun;39(3):385-99 PMID: 4955831
  17. Studies on the isolation of an infection-protective antigen from Psudomonas aeruginosa.
    Surg Gynecol Obstet. 1966 Nov;123(5):965-77 PMID: 4959020
  18. Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state.
    J Exp Med. 1969 Jun 1;129(6):1385-95 PMID: 4977284
  19. Prevention of invasive pseudomonas infection in burns with a new vaccine.
    Arch Surg. 1969 Aug;99(2):249-56 PMID: 4978523
  20. Isolation and characterization of antigenic components of a new heptavalent Pseudomonas vaccine.
    Nat New Biol. 1971 Feb 17;229(7):209-10 PMID: 5281014
  21. Susceptibility of burned mice to Pseudomonas aeruginosa and protection by vaccination.
    Ann Surg. 1966 Apr;163(4):603-10 PMID: 5934635
  22. Outer-membrane protein and lipopolysaccharide serotyping of Neisseria meningitidis by inhibition of a solid-phase radioimmunoassay.
    Infect Immun. 1977 Nov;18(2):424-33 PMID: 72735
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1978-12-00
Pages
919-25
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC422244
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com